Jakarta, July 13 -- The Indonesian Health Ministry partnered with global biopharmaceutical giant Takeda to establish the country's first plasma-derived medicinal product (PDMP) ecosystem, supported by an initial US$30 million investment.

The initiative aims to significantly strengthen national health resilience and expand public access to essential plasma-based therapies across the archipelago.

Health Minister Budi Gunadi Sadikin stated that the landmark agreement reflects the government's firm commitment to localizing advanced healthcare manufacturing and shielding the country from global supply chain vulnerabilities.

"Through this partnership with Takeda, we hope to strengthen the national healthcare system while preparing Indonesia ...